Lys Therapeutics (private company)
See something wrong or missing? Let us know
Offices:Caen
Business model:B2B
Lys Therapeutics is a France-based biotech startup that develops therapies against neurovascular and neurodegenerative diseases (stroke, multiple sclerosis, Parkinson's disease, etc.).
Investors:
we tracked 2 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 5.69M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Lys Therapeutics
Name | Criteria | |
---|---|---|
![]() |
Ability Pharma
63%
|
|
![]() |
Biograil
63%
|
|
![]() |
Cell-Easy
63%
|
|
![]() |
Curida
63%
|
|
![]() |
Gradientech
63%
|
|
![]() |
Sarcura
63%
|
|
![]() |
Theolytics
63%
|
|
![]() |
Bactolife
63%
|
|
![]() |
PEP-Therapy
63%
|
|
![]() |
Exciva
63%
|
|